Tag: focal laser ablation

At the 2025 AUA annual meeting, focal therapy took center stage as a proven option for prostate cancer. Backed by studies like PIVOT and ProtecT and enabled by modern imaging, it now offers targeted treatment that addresses the shortcomings of surgery and radiation. keep reading

When choosing prostate cancer treatment, it’s not just the procedure that matters—it’s the doctor’s skill. Research shows performance plays a major role in both cancer control and quality of life, underscoring why experience and technique should guide your decision. keep reading

What if prostate cancer treatment didn’t mean choosing between surgery, radiation, or living with uncertainty? Focal therapy, guided by MRI, targets only the cancer while sparing healthy tissue, helping men avoid the “gray area blues” with confidence and peace of mind. keep reading

For men seeking precision and quality of life, focal therapy offers a powerful alternative. By targeting tumors while sparing healthy tissue, treatments such as MRgFUS, TULSA, and Focal Laser Ablation help control prostate cancer and preserve urinary and sexual function. keep reading

Gleason 3+3 prostate cancer is often considered low-risk—so low that some experts say it shouldn’t even be called cancer at all. But could a new label change how patients view their diagnosis and choices? The answer may reshape the future of prostate cancer care. keep reading

Active Surveillance helps men with low-risk prostate cancer avoid overtreatment, but anxiety and repeated biopsies can take a toll. A new approach—Super Active Surveillance—combines MRI monitoring with focal therapy, offering peace of mind while keeping future treatment options open. keep reading

What’s harder—treating prostate cancer, or living with the knowledge it’s still inside you? Research shows Active Surveillance may lead to significant anxiety and depression for some patients, raising important questions about how to balance safety, treatment, and peace of mind. keep reading

An essential part of planning treatment for prostate cancer (PCa) is determining its size and location. Where and how big is it? If the tumor is found early when it is small and contained within the gland, it is called localized. In this case, the patient is a candidate for a local treatment with curative keep reading

The strategy of using active surveillance (AS) is increasingly recommended to low-risk prostate cancer (PCa) patients as a way to avoid or delay overtreatment. This is a new way of thinking; before the New Millennium, PCa was assumed to be multi-focal and most men with more than 10 years of life expectancy were hurried into surgery or radiation. Today’s terminology includes words that might have been meaningless a decade ago, e.g. indolent cancer, very low risk disease, and focal disease are all consistent with the growing movement toward AS. keep reading

Radiation for prostate cancer can come with long-term sexual side effects that aren’t always discussed upfront. While erectile dysfunction is well known, new research highlights issues with ejaculation, including reduced volume and discomfort. Patients deserve full transparency about these risks before choosing treatment. Learn why informed decision-making is crucial. keep reading